newsfilter
← Latest News
Business Wire·

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results

Showcased 20 presentations at the 27th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting demonstrating progression of neurology-focused preclinical pipeline, including additional data from novel